dihexa stability ph aqueous solution (PNB-0408) | c-Met/HGFR Activator Dihexa · Disguised Alpha

developmental code PNB-0408) is a synthetic small oligopeptide derived from angiotensin IV (AngIV), engineered to overcome AngIVs limitations as a research tool by adding lipophilic modifications that confer oral bioavailability and blood-brain barrier permeability

Although not readily used in the UK due to ongoing regulatory ambiguities, they are increasingly prescribed in other countries and subject to intensive ongoing research

[DOI] [PMC free article] [PubMed] [Google Scholar] Bergasa NV, Talbot TL, Alling DW, Schmitt JM, Walker EC, Baker BL, Korenman JC, Park Y, Hoofnagle JH, Jones EA

Dose Range: TB-500: 1,250 mcg per injection